176 related articles for article (PubMed ID: 17983687)
1. Structure-function analysis of the antiangiogenic ATWLPPR peptide inhibiting VEGF(165) binding to neuropilin-1 and molecular dynamics simulations of the ATWLPPR/neuropilin-1 complex.
Starzec A; Ladam P; Vassy R; Badache S; Bouchemal N; Navaza A; du Penhoat CH; Perret GY
Peptides; 2007 Dec; 28(12):2397-402. PubMed ID: 17983687
[TBL] [Abstract][Full Text] [Related]
2. Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1.
Starzec A; Vassy R; Martin A; Lecouvey M; Di Benedetto M; Crépin M; Perret GY
Life Sci; 2006 Nov; 79(25):2370-81. PubMed ID: 16959272
[TBL] [Abstract][Full Text] [Related]
3. A peptide competing with VEGF165 binding on neuropilin-1 mediates targeting of a chlorin-type photosensitizer and potentiates its photodynamic activity in human endothelial cells.
Tirand L; Frochot C; Vanderesse R; Thomas N; Trinquet E; Pinel S; Viriot ML; Guillemin F; Barberi-Heyob M
J Control Release; 2006 Mar; 111(1-2):153-64. PubMed ID: 16423422
[TBL] [Abstract][Full Text] [Related]
4. Branched pentapeptides as potent inhibitors of the vascular endothelial growth factor 165 binding to Neuropilin-1: Design, synthesis and biological activity.
Tymecka D; Puszko AK; Lipiński PFJ; Fedorczyk B; Wilenska B; Sura K; Perret GY; Misicka A
Eur J Med Chem; 2018 Oct; 158():453-462. PubMed ID: 30241012
[TBL] [Abstract][Full Text] [Related]
5. Orf virus VEGF-E NZ2 promotes paracellular NRP-1/VEGFR-2 coreceptor assembly via the peptide RPPR.
Cébe-Suarez S; Grünewald FS; Jaussi R; Li X; Claesson-Welsh L; Spillmann D; Mercer AA; Prota AE; Ballmer-Hofer K
FASEB J; 2008 Aug; 22(8):3078-86. PubMed ID: 18467594
[TBL] [Abstract][Full Text] [Related]
6. Sugar-based peptidomimetics as potential inhibitors of the vascular endothelium growth factor binding to neuropilin-1.
Novoa A; Pellegrini-Moïse N; Bechet D; Barberi-Heyob M; Chapleur Y
Bioorg Med Chem; 2010 May; 18(9):3285-98. PubMed ID: 20363638
[TBL] [Abstract][Full Text] [Related]
7. Molecular modelling, synthesis and biological evaluation of peptide inhibitors as anti-angiogenic agent targeting neuropilin-1 for anticancer application.
Kamarulzaman EE; Vanderesse R; Gazzali AM; Barberi-Heyob M; Boura C; Frochot C; Shawkataly O; Aubry A; Wahab HA
J Biomol Struct Dyn; 2017 Jan; 35(1):26-45. PubMed ID: 26766582
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationship study of tetrapeptide inhibitors of the Vascular Endothelial Growth Factor A binding to Neuropilin-1.
Tymecka D; Lipiński PFJ; Fedorczyk B; Puszko A; Wileńska B; Perret GY; Misicka A
Peptides; 2017 Aug; 94():25-32. PubMed ID: 28627371
[TBL] [Abstract][Full Text] [Related]
9. The original Pathologische Anatomie Leiden-Endothelium monoclonal antibody recognizes a vascular endothelial growth factor binding site within neuropilin-1.
Jaalouk DE; Ozawa MG; Sun J; Lahdenranta J; Schlingemann RO; Pasqualini R; Arap W
Cancer Res; 2007 Oct; 67(20):9623-9. PubMed ID: 17942890
[TBL] [Abstract][Full Text] [Related]
10. Discovery of novel inhibitors of vascular endothelial growth factor-A-Neuropilin-1 interaction by structure-based virtual screening.
Starzec A; Miteva MA; Ladam P; Villoutreix BO; Perret GY
Bioorg Med Chem; 2014 Aug; 22(15):4042-8. PubMed ID: 24961874
[TBL] [Abstract][Full Text] [Related]
11. Peptide-conjugated chlorin-type photosensitizer binds neuropilin-1 in vitro and in vivo.
Thomas N; Bechet D; Becuwe P; Tirand L; Vanderesse R; Frochot C; Guillemin F; Barberi-Heyob M
J Photochem Photobiol B; 2009 Aug; 96(2):101-8. PubMed ID: 19464192
[TBL] [Abstract][Full Text] [Related]
12. Metabolic profile of a peptide-conjugated chlorin-type photosensitizer targeting neuropilin-1: an in vivo and in vitro study.
Tirand L; Thomas N; Dodeller M; Dumas D; Frochot C; Maunit B; Guillemin F; Barberi-Heyob M
Drug Metab Dispos; 2007 May; 35(5):806-13. PubMed ID: 17283031
[TBL] [Abstract][Full Text] [Related]
13. Expression of the vascular endothelial growth factor receptor neuropilin-1 in the human endometrium.
Hess AP; Schanz A; Baston-Buest DM; Hirchenhain J; Stoff-Khalili MA; Bielfeld P; Kruessel JS
J Reprod Immunol; 2009 Jan; 79(2):129-36. PubMed ID: 18996601
[TBL] [Abstract][Full Text] [Related]
14. VEGF-A165 induces human aortic smooth muscle cell migration by activating neuropilin-1-VEGFR1-PI3K axis.
Banerjee S; Mehta S; Haque I; Sengupta K; Dhar K; Kambhampati S; Van Veldhuizen PJ; Banerjee SK
Biochemistry; 2008 Mar; 47(11):3345-51. PubMed ID: 18284215
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationship study of a small cyclic peptide H-c[Lys-Pro-Glu]-Arg-OH: a potent inhibitor of Vascular Endothelial Growth Factor interaction with Neuropilin-1.
Grabowska K; Puszko AK; Lipiński PF; Laskowska AK; Wileńska B; Witkowska E; Perret GY; Misicka A
Bioorg Med Chem; 2017 Jan; 25(2):597-602. PubMed ID: 27889287
[TBL] [Abstract][Full Text] [Related]
16. Structural basis for the interaction of a vascular endothelial growth factor mimic peptide motif and its corresponding receptors.
Giordano RJ; Anobom CD; Cardó-Vila M; Kalil J; Valente AP; Pasqualini R; Almeida FC; Arap W
Chem Biol; 2005 Oct; 12(10):1075-83. PubMed ID: 16242650
[TBL] [Abstract][Full Text] [Related]
17. The Neuropilin-1 Inhibitor, ATWLPPR Peptide, Prevents Experimental Diabetes-Induced Retinal Injury by Preserving Vascular Integrity and Decreasing Oxidative Stress.
Wang J; Wang S; Li M; Wu D; Liu F; Yang R; Ji S; Ji A; Li Y
PLoS One; 2015; 10(11):e0142571. PubMed ID: 26554379
[TBL] [Abstract][Full Text] [Related]
18. Molecular dynamics-solvated interaction energy studies of protein-protein interactions: the MP1-p14 scaffolding complex.
Cui Q; Sulea T; Schrag JD; Munger C; Hung MN; Naïm M; Cygler M; Purisima EO
J Mol Biol; 2008 Jun; 379(4):787-802. PubMed ID: 18479705
[TBL] [Abstract][Full Text] [Related]
19. Neuropilin structure governs VEGF and semaphorin binding and regulates angiogenesis.
Geretti E; Shimizu A; Klagsbrun M
Angiogenesis; 2008; 11(1):31-9. PubMed ID: 18283547
[TBL] [Abstract][Full Text] [Related]
20. L1 on ovarian carcinoma cells is a binding partner for Neuropilin-1 on mesothelial cells.
Stoeck A; Schlich S; Issa Y; Gschwend V; Wenger T; Herr I; Marmé A; Bourbie S; Altevogt P; Gutwein P
Cancer Lett; 2006 Aug; 239(2):212-26. PubMed ID: 16377081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
